All stock lists
RenovoRx, Inc. (NASDAQ:RNXT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.31+0.02 (+1.55%)
Insider Score
––Not scored
RNXT Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
RNXT Stock Insider Trading Activity
RNXT stock’s insider trading shows 1 purchase for an estimated $19.75K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VOLL MARK CFO | Award | 80,000 | — | — | 56.2% | 222,380 | Sep 10, 2026 | — | Form 4 |
| VOLL MARK CFO | Buy | 25,000 | $0.79 | $19.75K | 21.3% | 142,380 | May 19, 2026 | BCFO BuyDilution | Form 4 |
| VOLL MARK CFO | Award | 80,000 | — | — | 214% | 117,380 | Apr 3, 2026 | — | Form 4 |
| VOLL MARK CFO | Award | 12,380 | — | — | 49.5% | 37,380 | Mar 25, 2026 | — | Form 4 |
| Bagai Shaun CEO | Buy | 24,300 | — | — | 8.4% | 313,357 | Mar 20, 2026 | CCluster BuyCEO BuyDilution | Form 4 |
| Marton Laurence Director | Buy | 9,720 | — | — | New | 9,720 | Mar 20, 2026 | CCluster BuyFirst BuyDilution | Form 4 |
| VOLL MARK CFO | Buy | 97,200 | — | — | New | 97,200 | Mar 20, 2026 | BCluster BuyFirst BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 10,000 | $1.00 | $10.00K | 1.3% | 798,460 | Jan 21, 2026 | DExec BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 9,795 | $0.86 | $8.42K | 1.3% | 788,460 | Dec 31, 2025 | FExec BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 205 | $0.83 | $170.15 | 0.0% | 778,665 | Dec 30, 2025 | DExec BuyDilution | Form 4 |
| Bagai Shaun CEO | Buy | 5,000 | $0.90 | $4.50K | 1.5% | 340,040 | Dec 18, 2025 | CCEO BuyDilution | Form 4 |
| Bagai Shaun CEO | Buy | 5,000 | $0.85 | $4.25K | 1.5% | 335,040 | Dec 17, 2025 | CFirst BuyCEO BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 12,000 | $0.85 | $10.20K | 1.6% | 778,460 | Dec 16, 2025 | DExec BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 10,000 | $0.96 | $9.60K | 1.3% | 766,460 | Dec 5, 2025 | DExec BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 12,000 | $0.80 | $9.60K | 1.6% | 756,460 | Nov 24, 2025 | CExec BuyDilution | Form 4 |
| Agah Ramtin Director | Buy | 10,000 | $0.80 | $8.00K | 1.4% | 744,460 | Nov 21, 2025 | CFirst BuyExec BuyDilution | Form 4 |
| RYAN UNA S Director | Other | 26,838 | $0.93 | $24.96K | 49.6% | 80,959 | Apr 22, 2022 | — | Form 4 |
| RYAN UNA S Director | Other | 16,206 | $1.62 | $26.25K | 20.0% | 97,165 | Apr 22, 2022 | — | Form 4 |
| RYAN UNA S Director | Other | 6,332 | $3.95 | $25.01K | 13.2% | 54,121 | Mar 3, 2022 | — | Form 4 |
| RYAN UNA S Director | Other | 47,789 | $4.19 | $200.24K | New | 47,789 | Mar 3, 2022 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Award (A) — Grant or award from the company, not a purchase
- Other (J) — Other acquisition or disposition — the filing explains it in a footnote
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.